Tsai, Wen-Hua
Fang, Yi-Ting
Huang, Tsuei-Yin
Chiang, Ying-Ju
Lin, Ching-Gong
Chang, Wen-Wei
Funding for this research was provided by:
GenMont Biotech Incorporation, Taiwan
Article History
Received: 8 December 2022
Accepted: 24 April 2023
First Online: 29 April 2023
Declarations
:
: The clinical study was approved by the Institutional Review Board in Antai- Tian-Sheng memorial Hospital (TSMH IRB No./ Protocol No.: 20–040-A, approval date: 06/07/2020), Antai Medical Care Cooperation, Donggang Township, Pingtung County, Taiwan) and performed in accordance with the relevant guidelines and regulations. The study was registered at ClinicalTrials. gov with approval number NCT04566549 (first posted date: 28/09/2020). Informed consent was obtained from all subjects and/or their legal guardians.
: Not applicable (the manuscript does not include details, images, or videos relating to an individual person).
: Financial competing interests: WHT, TYH, and YJC are employed by GenMont Biotech Incorporation. YTF is an academic consultant of GenMont Biotech Incorporation. These authors declares that they have no competing interests: CGL and WWC.